Researchers announced this week the first large-scale randomized controlled trial of AI for screening mammography in the U.S.
This newsletter was originally sent with stories that had been previously included this week — here is the new slate of stories, with our apologies. Thanks for reading. |
|
|
In case you missed it - A quest to end breast cancer slows as the Trump-Harvard dispute drags on, WBUR
- Women who miss first breast cancer screening at '40% higher risk' of dying from the disease, the Guardian
- From the STAT archives: My eight-year struggle to return recalled breast implants
|
|
Check out more exclusive coverage with a STAT+ subscription | Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles. |
|
| STAT, 1 Exchange Place, Boston, MA | ©2025, All Rights Reserved. | |
|
No comments